TradeFlare's AI research teams analysed MDGL on 4 market nights between April 27, 2026 and May 12, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| May 12, 2026 | BUY | $497.03 | $537.13 / $422.86 | +0.3% | -7.6% | The fundamental outlook is strong, but technicals are neutral and near resistance, requiring a clearer breakout. |
| May 11, 2026 | HOLD | $510.04 | — / — | +5.1% | -4.0% | Continued strong adoption and sales growth of Rezdiffra. |
| April 28, 2026 | BUY | $520.09 | $575.00 / $425.00 | -2.8% | +2.1% | The fundamental and sentiment catalysts suggest a medium-term upward trend. |
| April 27, 2026 | BUY | $512.39 | — / — | -0.3% | +0.8% | The current market regime is neutral, and while the fundamental and sentiment analyses are bullish, the technical analysis is neutral, and the risk score is high. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.